WO1997009616A1 - Stain and capillary slide to detect animal and plant cells - Google Patents

Stain and capillary slide to detect animal and plant cells Download PDF

Info

Publication number
WO1997009616A1
WO1997009616A1 PCT/GB1996/002192 GB9602192W WO9709616A1 WO 1997009616 A1 WO1997009616 A1 WO 1997009616A1 GB 9602192 W GB9602192 W GB 9602192W WO 9709616 A1 WO9709616 A1 WO 9709616A1
Authority
WO
WIPO (PCT)
Prior art keywords
slide
stain
blood
base
cover
Prior art date
Application number
PCT/GB1996/002192
Other languages
French (fr)
Inventor
Roger Clampitt
Ronald Barron
Original Assignee
Zynocyte Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zynocyte Limited filed Critical Zynocyte Limited
Priority to JP9510980A priority Critical patent/JPH11515095A/en
Priority to EP96929428A priority patent/EP0848818A1/en
Priority to AU68841/96A priority patent/AU6884196A/en
Publication of WO1997009616A1 publication Critical patent/WO1997009616A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing

Definitions

  • the present invention relates to a stain, a slide and a method of preparation of a blood sample.
  • red blood cells RBCs
  • WBCs white blood cells
  • the numbers of each type of cell may be controlled by complex body mechanisms. Any variation from the normal range can indicate serious physiological or pathological changes within the body. Therefore, it is important to be able to determine the number of each type of cell or particle in the blood. This may be achieved by preparation of a suitable sample of the blood or other biological fluid or material of a patient or plant and then screening the sample, for example under a microscope.
  • the stain may be used to stain cellular components of plants, and in this specification "plants" should be taken as inclusive of fungi, bacteria and the like present in water and other environmental samples.
  • a sample may be prepared by first preparing a blood smear on a slide, allowing the smear to dry in air, then dipping the smear in a bath of methanol or the like (to fix the cells) and finally staining the smear.
  • stains when the components are mixed, may only be stable for a short time, for example 2-3 days, and if purchased in bulk may easily become contaminated if not used quickly. Further, some stains may differentiate only certain blood cell types, and/or may only be effective in staining the blood cells of certain animal species.
  • An object of the invention is to provide a means whereby a non-skilled person may produce good quality test specimens without difficulty.
  • the present invention provides a stain for animal or plant samples comprising the following components :-
  • the buffer is Citric acid, Trisodium salt, dihydrate F. . 294.1 (Formula C 6 H 5 O y Na 3 .2H 2 0) .
  • the membrane modifier is 2-Ethoxyethanol (Ethyleneglycolmonoethyl ether) F.W. 90.12 (Formula C 2 H 5 OCH 2 CH 2 OH) .
  • the staining compound is Azure B (c.1.52010; Azure 1 Certified by BSC differentiating cellular RNA and DNA in plant tissue) F.W. 305.8. ( v Formula or a derivative of Azure B.
  • the Azure B or derivative thereof has a dye content of approximately 80%.
  • the solvent is deionised or distilled water.
  • the stain may be used to stain a sample of blood taken from a human or an animal, and may differentiate the types of cells and/or particles therein.
  • the stain of the present invention has the advantages of having good stability at room temperature, is able to give a good contrast between types of blood cells and intracellular structures, and may be effectively used to stain the blood of a variety of different animal species.
  • the present invention provides a method of staining comprising mixing a volume of liquid with a stain having the following components:
  • the stain has the following components:
  • Citric acid trisodium salt, dihydrate F.W. 294.1 (Formula C 6 H 5 0 ? Na 3 .2H 2 0) ;
  • the Azure B has a dye content of approximately 80%.
  • the liquid may be blood.
  • the method of staining of the present invention has the advantage that it consists of a quick and simple one stage process, and can be used to stain a fresh liquid blood sample.
  • the blood and the stain may be mixed in the ratio 1:4 and may be mixed by gentle agitation.
  • the mixture is allowed to stand for between one minute and sixty minutes at a temperature of between 15°C and 60°C.
  • the present invention provides a slide adapted to draw liquid into itself by capillary action.
  • the liquid may be a sample of stained or unstained blood.
  • An advantage of the slide of the present invention is that a good quality monolayer blood film may be produced without the need for smearing, since a drop of blood may simply be introduced to one end of the capillary chamber and allowed to flow by capillary action along the length of the chamber to form a monolayer of cells. Therefore the slide of the present invention is easy to use and facilitates the quick and simple preparation of a fresh blood sample which may then be analyzed in the conventional way.
  • the slide comprises a base and a cover placed together to form a capillary chamber.
  • a further advantage of a slide in accordance with the invention is that the capillary chamber provides for a controlled or known volume of test sample, such as blood, to be examined, thereby enabling quantative analysis. Conventional slides are useful for qualative analysis only.
  • the base and the cover are made of a glass and/or a plastic material.
  • the glass is a very flat glass, such as float glass.
  • the cover may be fixed to the base using an adhesive which may act as a sealant of the capillary chamber.
  • microspheres may be used to separate the cover from the base, thereby ensuring the gap between the cover and the base is of a known distance.
  • the microspheres may be between 5 and 20 microns in diameter and made of Vinyl-Benzene and/or polystyrene.
  • the microspheres are preferably contained in an aqueous solution, and provided that they are not soluble in the adhesive, may be mixed with the adhesive prior to application on the base or cover.
  • the capillary chamber may be defined by providing grooves in the base, which act to prevent the flow of the adhesive into the chamber, which preferably is of controlled volume.
  • the glass or plastics base and or cover may be treated or coated to assist or retard the flow of the test sample within the slide.
  • the slide comprises a base made of plastics, either by an extrusion or moulding process, the base having a concave or recessed portion of known volume, and a flat or planar cover.
  • the present invention provides a method of preparation of a blood sample that comprises the steps of staining a quantity of blood and introducing the stained blood to a slide which draws the stained blood into itself by capillary action.
  • the method of preparation of the present invention has the advantage of being quick and easy, producing a good quality monolayer blood film, for example to facilitate blood cell counts. No special skills or techniques are necessary, and the method is convenient for use on a small scale, for example in a general practitioner's surgery. Further, only a small amount of blood is necessary, therefore reducing trauma to small animals when blood is taken.
  • the present invention provides a kit comprising a stain having the following components:
  • a stain according to the present invention is prepared in the following way:
  • Trisodium citrate (16.0g) is dissolved in distilled water and made up to 1.01 (equivalent to 50% isotonicity for mammalian red blood cells). 2-Ethoxyethanol (200ml) and Trisodium citrate solution (800ml) are mixed by stirring. (This is the primary buffer solution.) pH of buffer (unadjusted) is 8.9. Azure B (l.Og) is added to 500ml of primary buffer and made up to 1.01. (This is the working stain). The working stain is filtered under gravity through Watmans 113V wet strengthened filter paper.
  • a sample of blood is taken from an animal and is added to the stain in the ratio of 1 part blood to 4 parts stain.
  • the blood and the stain are mixed by gentle agitation, and the mixture is allowed to incubate for between 1 minute and 60 minutes at a temperature of between 15°C and 60°C.
  • Figure 1 depicts a side elevation of a preferred embodiment of a slide in accordance with the present invention
  • Figure 2 is a top view the slide shown in Figure 1;
  • Figure 3 is an side view of an alternative embodiment of slide of Figure 3.
  • Figure 4 is a top view of the slide of Figure 3.
  • the slide 1 has a base 2 and a cover 3, both being manufactured from a glass material.
  • the dimensions of the base 2 and the cover 3 are 25mm x 40mm x 1.1mm and 15mm x 5mm x 0.3- 0.6mm, respectively.
  • the slide 1 is also provided with microspheres 4, which act as spacers situated along the side edges of the cover 3. These spacers have a thickness of approximately 5.0 ⁇ m, but in other embodiments of the invention the spacers may have a thickness of, say, between 4.0 and 25.0 ⁇ m.
  • the cover 3 is attached to the base 2 by an adhesive 5 along the edges of the cover 3 and the sides of the spacers thus forming a capillary chamber 6.
  • Grooves 7 are provided to prevent the flow of adhesive 5 into the capillary chamber 6.
  • a drop (1.0 - 5.0 ⁇ l) of the stained blood (not shown), is introduced to either of the openings 8 of the capillary chamber 6.
  • the blood is then drawn into the capillary chamber 6 by capillary action, forming a fine layer between the cover 3, the base 2 and the spacers.
  • the adhesive strips 5 act as a sealant of the capillary chamber 6 to prevent leakage.
  • the slide 1 containing the stained blood is then analysed by any suitable method.
  • the base 2 is made of a plastics moulding.
  • the capillary chamber 6 is thus provided by a recess formed as part of the moulded base 2.
  • the cover 3 may be glass or plastics.
  • An adhesive or tape 5 is shown to fix the cover 3 to the base 2.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)

Abstract

A stain is provided having an acidic or basic buffer, a membrane modifier, a staining compound and a solvent, the stain being suitable for use in preparing blood or other samples from animals or plants. The stain may be used in connection with a slide which is described as adapted to draw liquid into itself by capillary action.

Description

STAIN AND CAPILLARY SLIDE TO DETECT ANIMAL AND PLANT CELLS.
The present invention relates to a stain, a slide and a method of preparation of a blood sample.
Various types of cells and particles may be found in the blood of a human or animal, for example, red blood cells (RBCs) and several forms of white blood cells (WBCs) . In a healthy individual, the numbers of each type of cell may be controlled by complex body mechanisms. Any variation from the normal range can indicate serious physiological or pathological changes within the body. Therefore, it is important to be able to determine the number of each type of cell or particle in the blood. This may be achieved by preparation of a suitable sample of the blood or other biological fluid or material of a patient or plant and then screening the sample, for example under a microscope. The stain may be used to stain cellular components of plants, and in this specification "plants" should be taken as inclusive of fungi, bacteria and the like present in water and other environmental samples.
Conventionally, a sample may be prepared by first preparing a blood smear on a slide, allowing the smear to dry in air, then dipping the smear in a bath of methanol or the like (to fix the cells) and finally staining the smear.
Conventional stains and staining methods may involve a series of complex and time consuming steps. As a result the whole staining process may take a considerable time to complete, for example may take an hour, and the operator should be skilled and experienced in order to obtain a satisfactory result. During the smearing process, cells and particles in the blood may not be distributed evenly or may be damaged and therefore become difficult or impossible to identify during screening.
In addition, many conventional stains, when the components are mixed, may only be stable for a short time, for example 2-3 days, and if purchased in bulk may easily become contaminated if not used quickly. Further, some stains may differentiate only certain blood cell types, and/or may only be effective in staining the blood cells of certain animal species.
In view of the problems and complexities outlined above, it is not convenient for samples to be prepared by these methods on a small scale or by a person who is not specialised in such techniques, for example in a surgery or a practice. As a result, blood is often sent to remote contract laboratories for analysis. This may be costly, require relatively large samples of blood to be supplied, and involve a considerable time delay. In addition, during transportation the blood may degenerate and the particles and cells therein may become damaged. An object of the invention is to provide a means whereby a non-skilled person may produce good quality test specimens without difficulty.
In one aspect, the present invention provides a stain for animal or plant samples comprising the following components :-
(i) An acidic or basic buffer whose tonicity can be varied depending on the nature of the material to be examined;
(ϋ) A fixative and organic membrane modifier;
(iϋ) A compound which stains nuclear and cytoplasmic components in the sample; and
(iv) A solvent.
Preferably the buffer is Citric acid, Trisodium salt, dihydrate F. . 294.1 (Formula C6H5OyNa3.2H20) .
Preferably, the membrane modifier is 2-Ethoxyethanol (Ethyleneglycolmonoethyl ether) F.W. 90.12 (Formula C2H5OCH2CH2OH) .
Preferably, the staining compound is Azure B (c.1.52010; Azure 1 Certified by BSC differentiating cellular RNA and DNA in plant tissue) F.W. 305.8. (vFormula
Figure imgf000005_0001
or a derivative of Azure B.
Preferably, the Azure B or derivative thereof has a dye content of approximately 80%.
Preferably, the solvent is deionised or distilled water. Typically, the stain may be used to stain a sample of blood taken from a human or an animal, and may differentiate the types of cells and/or particles therein.
The stain of the present invention has the advantages of having good stability at room temperature, is able to give a good contrast between types of blood cells and intracellular structures, and may be effectively used to stain the blood of a variety of different animal species.
In another aspect, the present invention provides a method of staining comprising mixing a volume of liquid with a stain having the following components:
(i) An acidic or basic buffer whose tonicity can be varied depending on the nature of the material to be examined;
(ϋ) A fixative and organic membrane modifier;
(iϋ) A compound which stains nuclear and cytoplasmic components in the sample; and
(iv) A solvent;
and allowing the mixture to stand.
Preferably, the stain has the following components:
(i) Citric acid, trisodium salt, dihydrate F.W. 294.1 (Formula C6H50?Na3.2H20) ;
(ii) 2-Ethoxyethanol ( Ethyleneglycolmonoethyl ether) F.W. 90.12 (Formula C2H5OCH2CH2OH) ; (iϋ) Azure B (c.1.52010; Azure 1 Certified by BSC differentiating cellular RNA and DNA in plant tissue) . F.W. 305.8 (Formula C15H16CIN3S) ; and
(iv) Deionised and/or distilled water;
Preferably, the Azure B has a dye content of approximately 80%.
Typically, the liquid may be blood.
The method of staining of the present invention has the advantage that it consists of a quick and simple one stage process, and can be used to stain a fresh liquid blood sample.
Typically, the blood and the stain may be mixed in the ratio 1:4 and may be mixed by gentle agitation.
Preferably, the mixture is allowed to stand for between one minute and sixty minutes at a temperature of between 15°C and 60°C.
In yet another aspect, the present invention provides a slide adapted to draw liquid into itself by capillary action.
Typically, the liquid may be a sample of stained or unstained blood.
An advantage of the slide of the present invention is that a good quality monolayer blood film may be produced without the need for smearing, since a drop of blood may simply be introduced to one end of the capillary chamber and allowed to flow by capillary action along the length of the chamber to form a monolayer of cells. Therefore the slide of the present invention is easy to use and facilitates the quick and simple preparation of a fresh blood sample which may then be analyzed in the conventional way.
Preferably, the slide comprises a base and a cover placed together to form a capillary chamber.
A further advantage of a slide in accordance with the invention is that the capillary chamber provides for a controlled or known volume of test sample, such as blood, to be examined, thereby enabling quantative analysis. Conventional slides are useful for qualative analysis only.
Preferably the base and the cover are made of a glass and/or a plastic material. Preferably, the glass is a very flat glass, such as float glass.
Typically, the cover may be fixed to the base using an adhesive which may act as a sealant of the capillary chamber.
During manufacture, microspheres may be used to separate the cover from the base, thereby ensuring the gap between the cover and the base is of a known distance. The microspheres may be between 5 and 20 microns in diameter and made of Vinyl-Benzene and/or polystyrene. The microspheres are preferably contained in an aqueous solution, and provided that they are not soluble in the adhesive, may be mixed with the adhesive prior to application on the base or cover.
The capillary chamber may be defined by providing grooves in the base, which act to prevent the flow of the adhesive into the chamber, which preferably is of controlled volume.
Optionally the glass or plastics base and or cover may be treated or coated to assist or retard the flow of the test sample within the slide.
Optionally the slide comprises a base made of plastics, either by an extrusion or moulding process, the base having a concave or recessed portion of known volume, and a flat or planar cover.
In a fourth aspect, the present invention provides a method of preparation of a blood sample that comprises the steps of staining a quantity of blood and introducing the stained blood to a slide which draws the stained blood into itself by capillary action.
The method of preparation of the present invention has the advantage of being quick and easy, producing a good quality monolayer blood film, for example to facilitate blood cell counts. No special skills or techniques are necessary, and the method is convenient for use on a small scale, for example in a general practitioner's surgery. Further, only a small amount of blood is necessary, therefore reducing trauma to small animals when blood is taken.
In a final aspect, the present invention provides a kit comprising a stain having the following components:
(i) An acidic or basic buffer whose tonicity can be varied depending on the nature of the material to be examined; (ii) fixative and organic membrane modifier;
(iii) A compound which stains nuclear and cytoplasmic components in the sample; and
(iv) A solvent,
and a slide adapted to draw liquid into itself by capillary action.
EXAMPLE
A stain according to the present invention is prepared in the following way:
Trisodium citrate (16.0g) is dissolved in distilled water and made up to 1.01 (equivalent to 50% isotonicity for mammalian red blood cells). 2-Ethoxyethanol (200ml) and Trisodium citrate solution (800ml) are mixed by stirring. (This is the primary buffer solution.) pH of buffer (unadjusted) is 8.9. Azure B (l.Og) is added to 500ml of primary buffer and made up to 1.01. (This is the working stain). The working stain is filtered under gravity through Watmans 113V wet strengthened filter paper.
A sample of blood is taken from an animal and is added to the stain in the ratio of 1 part blood to 4 parts stain. The blood and the stain are mixed by gentle agitation, and the mixture is allowed to incubate for between 1 minute and 60 minutes at a temperature of between 15°C and 60°C.
Embodiments of the present invention will now be described by way of example with reference to the accompanying drawings, in which: Figure 1 depicts a side elevation of a preferred embodiment of a slide in accordance with the present invention;
Figure 2 is a top view the slide shown in Figure 1;
Figure 3 is an side view of an alternative embodiment of slide of Figure 3; and
Figure 4 is a top view of the slide of Figure 3.
Referring firstly to Figures 1 and 2, the slide 1 has a base 2 and a cover 3, both being manufactured from a glass material. The dimensions of the base 2 and the cover 3 are 25mm x 40mm x 1.1mm and 15mm x 5mm x 0.3- 0.6mm, respectively.
The slide 1 is also provided with microspheres 4, which act as spacers situated along the side edges of the cover 3. These spacers have a thickness of approximately 5.0μm, but in other embodiments of the invention the spacers may have a thickness of, say, between 4.0 and 25.0μm.
The cover 3 is attached to the base 2 by an adhesive 5 along the edges of the cover 3 and the sides of the spacers thus forming a capillary chamber 6. Grooves 7 are provided to prevent the flow of adhesive 5 into the capillary chamber 6.
A drop (1.0 - 5.0μl) of the stained blood (not shown), is introduced to either of the openings 8 of the capillary chamber 6.
The blood is then drawn into the capillary chamber 6 by capillary action, forming a fine layer between the cover 3, the base 2 and the spacers. The adhesive strips 5 act as a sealant of the capillary chamber 6 to prevent leakage.
The slide 1 containing the stained blood is then analysed by any suitable method.
In Figures 3 and 4, the base 2 is made of a plastics moulding. The capillary chamber 6 is thus provided by a recess formed as part of the moulded base 2. The cover 3 may be glass or plastics. An adhesive or tape 5 is shown to fix the cover 3 to the base 2.

Claims

1. A stain for animal or plant samples comprising the following components :-
(i) An acidic or basic buffer whose tonicity can be varied depending on the nature of the material to be examined;
(ϋ) A fixative and organic membrane modifier;
(ϋi) A compound which stains nuclear and cytoplasmic components in the sample; and
(iv) A solvent.
2. A stain as claimed in Claim 1 wherein the buffer is Citric acid, Trisodium salt, dihydrate F.W. 294.1 (xFormula C,faHJn/NaJ.2HZ,0)' .
3. A stain as claimed in Claim 1 or Claim 2 wherein the membrane modifier is 2-Ethoxyethanol (Ethyleneglycolmonoethyl ether) F.W. 90.12 (Formula C2H5OCH2CH2OH) .
4. A stain as claimed in any preceding Claim wherein the staining compound is Azure B (c.1.52010; Azure 1 Certified by BSC differentiating cellular RNA and DNA in plant tissue) F.W. 305.8. (xFormula C,CHl,£bCIN,JS)' or a derivative of Azure B.
5. A stain as claimed in Claim 4 wherein the Azure B or derivative thereof has a dye content of approximately 80%.
6. A stain as claimed in any one of the preceding Claims wherein the solvent is deionised or distilled water.
7. A stain as claimed in any one of the preceding Claims suitable to be used to stain a sample of blood taken from a human or an animal, and to differentiate the types of cells and/or particles therein.
8. A method of staining comprising mixing a volume of liquid with a stain as claimed in any one of the preceding Claims and allowing the mixture to stand.
9. A method as claimed in Claim 8 wherein the liquid is blood.
10. A method as claimed in Claim 9 wherein the blood and the stain are mixed in the ratio 1:4.
11. A method as claimed in any one of Claims 8 to 10 wherein the liquid and the stain are mixed by gentle agitation.
12. A method as claimed in any one of Claims 8 to 10 wherein the mixture is allowed to stand for between one minute and sixty minutes at a temperature of between 15°C and 60°C.
13. A slide adapted to draw liquid into itself by capillary action.
14. A slide as claimed in Claim 13 wherein the liquid is a sample of stained or unstained blood.
15. A slide as claimed in Claim 13 or 14 comprising a base and a cover placed together to form a capillary chamber.
16. A slide as claimed in Claim 15 wherein the base and the cover are made of a glass and/or a plastic material.
17. A slide as claimed in Claim 15 wherein the base and the cover are made of a very flat glass, such as float glass.
18. A slide as claimed in any one of Claims 15 to 17 wherein the cover is fixed to the base using an adhesive which may act as a sealant of the capillary chamber.
19. A slide as claimed in any one of Claims 15 to 18 wherein microspheres are used to separate the cover from the base.
20. A slide as claimed in Claim 19 wherein the microspheres may be between 5 and 20 microns in diameter and made of Vinyl-Benzene and/or polystyrene.
21. A slide as claimed in Claim 19 or 20 wherein the microspheres are contained in an aqueous solution.
22. A slide as claimed in any one of Claims 15 to 21 wherein the capillary chamber is defined by providing grooves in the base, which act to prevent the flow of the aqueous solution into the chamber.
23. A slide as claimed in any one of Claims 15 to 22 wherein the base and or cover may be treated or coated to assist or retard the flow of the test sample within the slide.
24. A slide as claimed in Claim 13 comprising a base made of plastics, either by an extrusion or moulding process, the base having a concave or recessed portion of known volume, and a flat or planar cover.
25. A method of preparation of a blood sample that comprises the steps of staining a quantity of blood as claimed in any one of Claims 9 to 12 and introducing the stained blood to a slide as claimed in any one of Claims 13 to 24.
26. A kit comprising a stain having the following components:
(i) An acidic or basic buffer whose tonicity can be varied depending on the nature of the material to be examined;
(ii) A fixative and organic membrane modifier;
(iϋ) A compound which stains nuclear and cytoplasmic components in the sample; and
(iv) A solvent,
and a slide adapted to draw liquid into itself by capillary action.
PCT/GB1996/002192 1995-09-06 1996-09-05 Stain and capillary slide to detect animal and plant cells WO1997009616A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP9510980A JPH11515095A (en) 1995-09-06 1996-09-05 Stain and capillary slides for detecting animal and plant cells
EP96929428A EP0848818A1 (en) 1995-09-06 1996-09-05 Stain and capillary slide to detect animal and plant cells
AU68841/96A AU6884196A (en) 1995-09-06 1996-09-05 Stain and capillary slide to detect animal and plant cells

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9518129.3A GB9518129D0 (en) 1995-09-06 1995-09-06 Stain and capillary slide
GB9518129.3 1995-09-06

Publications (1)

Publication Number Publication Date
WO1997009616A1 true WO1997009616A1 (en) 1997-03-13

Family

ID=10780244

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1996/002192 WO1997009616A1 (en) 1995-09-06 1996-09-05 Stain and capillary slide to detect animal and plant cells

Country Status (6)

Country Link
EP (1) EP0848818A1 (en)
JP (1) JPH11515095A (en)
AU (1) AU6884196A (en)
CA (1) CA2230889A1 (en)
GB (1) GB9518129D0 (en)
WO (1) WO1997009616A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911815B2 (en) 2009-11-13 2014-12-16 Ventana Medical Systems, Inc. Thin film processing apparatuses for adjustable volume accommodation
USD728120S1 (en) 2013-03-15 2015-04-28 Ventana Medical Systems, Inc. Arcuate member for moving liquids along a microscope slide
US9176121B2 (en) 2004-02-13 2015-11-03 Roche Diagnostics Hematology, Inc. Identification of blood elements using inverted microscopy
US9498791B2 (en) 2009-11-13 2016-11-22 Ventana Medical Systems, Inc. Opposables and automated specimen processing systems with opposables
US10746752B2 (en) 2009-11-13 2020-08-18 Ventana Medical Systems, Inc. Opposables and automated specimen processing systems with opposables

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2014002844A (en) * 2011-09-13 2014-07-09 Koninkl Philips Nv System and kit for preparing a cytological sample for examination.
JP2014002046A (en) * 2012-06-19 2014-01-09 Murazumi Kogyo Kk Preparation for inspection of liquid sample
JP2019101021A (en) * 2017-11-28 2019-06-24 東ソー株式会社 Biological material retainer and method for detecting biological material

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
E. SCHERER ET AL.: "Improved immunocytochemical staining of carcinogen-DNA adducts by a capillary slot block system.", THE JOURNAL OF HISTOCHEMISTRY AND CYTOCHEMISTRY, vol. 38, no. 3, 1990, WASHINGTON DC USA, pages 433 - 436, XP000614357 *
J.A. REED ET AL.: "Complete one-hour immunocytochemistry based on capillary action.", BIOTECHNIQUES, vol. 13, no. 3, 1992, LONDON UK, pages 438 - 440, XP000616032 *
R.K. KUMAR ET AL.: "Immunogold-silver staining by capillary action.", AMERICAN JOURNAL OF CLINICAL PATHOLOGY, vol. 92, no. 6, 1989, ST. LOUIS MI USA, pages 773 - 778, XP000614312 *
U. MUSCATELLO ET AL.: "Effect of the tonicity of some negative-staining solutions on the elementary structure of membrane-bounded systems.", JOURNAL OF ULTRASTRUCTURE RESEARCH, vol. 25, no. 1-2, 1968, NEW YORK NY USA, pages 73 - 83, XP000614389 *
U.T. BRUNK ET AL.: "The demonstration of acid phosphatase in in vitro cultured tissue cells. Studies on the significance of fixation, tonicity and permeability.", HISTOCHEMICAL JOURNAL, vol. 4, no. 4, 1972, LONDON UK, pages 349 - 363, XP000614310 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9176121B2 (en) 2004-02-13 2015-11-03 Roche Diagnostics Hematology, Inc. Identification of blood elements using inverted microscopy
US8911815B2 (en) 2009-11-13 2014-12-16 Ventana Medical Systems, Inc. Thin film processing apparatuses for adjustable volume accommodation
US9498791B2 (en) 2009-11-13 2016-11-22 Ventana Medical Systems, Inc. Opposables and automated specimen processing systems with opposables
US9618430B2 (en) 2009-11-13 2017-04-11 Ventana Medical Systems, Inc. Thin film processing apparatuses for adjustable volume accommodation
US10746752B2 (en) 2009-11-13 2020-08-18 Ventana Medical Systems, Inc. Opposables and automated specimen processing systems with opposables
USD728120S1 (en) 2013-03-15 2015-04-28 Ventana Medical Systems, Inc. Arcuate member for moving liquids along a microscope slide
USD772424S1 (en) 2013-03-15 2016-11-22 Ventana Medical Systems, Inc. Arcuate member for moving liquids along a microscope slide

Also Published As

Publication number Publication date
GB9518129D0 (en) 1995-11-08
EP0848818A1 (en) 1998-06-24
AU6884196A (en) 1997-03-27
JPH11515095A (en) 1999-12-21
CA2230889A1 (en) 1997-03-13

Similar Documents

Publication Publication Date Title
EP0117262B1 (en) Processes and devices for examinations on immobilised biological material
Smith The blood cells and tunic of the ascidian Halocynthia aurantium (Pallas). I. Hematology, tunic morphology, and partition of cells between blood and tunic
DE69230318T3 (en) REAGENT COMPOSITIONS FOR ANALYTICAL TESTS
Bloem Fluorescent staining of microbes for total direct counts
Tooze et al. The occurrence and possible significance of haemoglobin in the chromosomal regions of mature erythrocyte nuclei of the newt Triturus cristatus cristatus
EP0597268A1 (en) Device and method of assaying whole blood for hdl cholesterol
US20060088814A1 (en) Enhanced cell preservative solution and methods for using same
CA1124623A (en) Polymer carrier and method for carrying out scientific, analytic and diagnostic examinations
DE3504715C2 (en)
CN112067764B (en) Method for evaluating skin inflammation relieving or repairing effect of cosmetic
Deane et al. Improved fixation for histological demonstration of glycogen and comparison with chemical determination in liver.
DE69333586T2 (en) METHOD AND COMPOSITION FOR PRESERVING ANTIGENES AND METHOD FOR THE USE OF CYTOLOGICAL MATERIAL PRODUCED BY SELF-PROCEDURE
DE2455369B2 (en) METHOD OF MANUFACTURING AN OBJECT CARRIER
EP0848818A1 (en) Stain and capillary slide to detect animal and plant cells
WO2006047252A1 (en) Enhanced cell preseravtive solution and methods for using same
DE3854326T2 (en) TREATMENT TECHNOLOGY FOR WHOLE BLOOD PATTERN.
Rofe Tissue culture and toxicology
Roozemond Ultramicrochemical determination of nucleic acids in individual cells using the Zeiss UMSP-I microspectrophotometer. Application to isolated rat hepatocytes of different ploidy classes
US3961039A (en) Urinary sediment stain
CN101570739B (en) Method for building psoriasis basic research models, and gas-liquid level transmembrane device
Ma et al. Pollen mitosis and pollen tube growth inhibition by SO2 in cultured pollen tubes of Tradescantia
FISHMAN et al. Enzymorphology: A study of free cells
Latner et al. Quantitative assay of lactate dehydrogenase isoenzymes by reflectance densitometry
RU2350951C2 (en) Method of colouring of eosinophilic granulocytes in sputum smears
Ornstein Tenuous but contingent connections

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1996929428

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2230889

Country of ref document: CA

Ref country code: CA

Ref document number: 2230889

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1997 510980

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1996929428

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1996929428

Country of ref document: EP